<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Brazilian Trials of Sinovac’s COVID-19 Vaccine Are Promising
Image Overlay - Brazilian Trials of Sinovac’s COVID-19 Vaccine Are Promising

Brazilian Trials of Sinovac’s COVID-19 Vaccine Are Promising

Brazilian Trials of Sinovac’s COVID-19 Vaccine Are Promising

Phase III trials of a COVID-19 vaccine developed by China's Sinovac Biotech Ltd have thus far demonstrated promising results, with the vaccine potentially available commercially by December. According to Sao Paulo’s Governor Joao Doria, 98 percent of elderly people dosed generated an immune response. Approximately 9,000 people are participating in the trial. Yourway has a local depot located in Sao Paulo with over 10,000 square feet of capacity with storage temperatures of up to -20 degrees Celsius.

Back to Index
Media

Upcoming Events

Precision in Pharma Supply Chain & Logistics Summit (Munich)

April 15-16, 2024
Science Congress Center Munich

GCSG 2024 US Conference

April 21-24, 2024
Naples, Florida

Media

Articles

The At-home Trial Experience: Leveraging value-chain to reach and retain patients

Open chat
Come chat with us!
Hello! How can I help you?